Reconciling conflicting clinical studies of antioxidant supplementation as HIV therapy: A mathematical approach

BMC Public Health

Volumn 9, Issue SUPPL. 1, 2009, Pages

  Van Gaalen, Rolina D ^a   Wahl, Lindi M ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CD4 LYMPHOCYTE COUNT; DIETARY INTAKE; DRUG EFFICACY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INTRAVENOUS DRUG ABUSE; MATHEMATICAL MODEL; VITAMIN SUPPLEMENTATION; CD4+ T LYMPHOCYTE; DIET SUPPLEMENTATION; FEMALE; IMMUNOLOGY; MALE; METABOLISM; PHYSIOLOGY; SUBSTANCE ABUSE; THEORETICAL MODEL;

ANTIOXIDANTS; APOPTOSIS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DIETARY SUPPLEMENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MODELS, THEORETICAL; REACTIVE OXYGEN SPECIES; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 72849152455     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-9-S1-S12     Document Type: Article

References (53)

1. NF-B activation by reactive oxygen species: fifteen years later. G Gloire S Legrand-Poels J Piette, Biochem Pharmacol 2006 72 1493 1505
2. An essential role for free radicals and derived species in signal transduction. HM Lander, The FASEB Journal 1997 11 118 124
3. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. S Devadas L Zaritskaya SG Rhee L Oberley MS Williams, J Exp Med 2002 195 59 70
4. Regulation of T-cell apoptosis by reactive oxygen species. DA Hildeman, Free Radical Biology & Medicine 2004 36 12 1496 1504
5. S Gropper J Smith J Groff, Advanced nutrition and human metabolism Wadsworth, Cengage Learning 2009
6. Contribution to characterization of oxidative stress in HIV/AIDS patients. L Gil G Martinez I Gonzalez A Tarinas A Alvarez A Giuliani R Molina R Tapanes J Perez OS Leon, Pharmacol Res 2003 47 217 224
7. Reactive oxygen species as cellular messengers. AU Khan T Wilson, Chemistry & Biology 1995 2 7 437 445
8. Biological origin of free radicals, and mechanisms of antioxidant protection. JM Gutteridge, Chemico-Biological Interactions 1994 91 133 140
9. Cellular response to oxidative stress: signaling for suicide and survival. JL Martindale NJ Holbrook, J Cell Physiol 2002 192 1 15
10. Is NF-B the sensor of oxidative stress? N Li M Karin, The FASEB Journal 1999 13 1137 1143
11. CK Sen H Sies PA Baeuerle, Antioxidant and redox regulation of genes Academic Press 2000
12. Oxidative stress in human immunodeficiency virus infection. N Isral MA Gougerot-Pocidalo, Cel l Molec Life Sciences 1997 53 864 870
13. Oxidative stress during viral infection: a review. KB Schwarz, Free Radical Biology and Medicine 1996 21 5 641 649
14. Vitamins C and E in adolescents and young adults with HIV infection. CB Stephenson GS Marquis RA Jacob LA Kruzich SD Douglas CM Wilson, Am J Clin Nutrit 2006 83 870 879
15. Immune activation and oxidative damage in HIV-positive and HIV-negative adolescents. CB Stephenson GS Marquis SD Douglas CM Wilson, J Acq Imm Defic Synd 2005 38 2 180 190
16. Hostile takeovers: viral appropriation of the NF-B pathway. J Hiscott H Kwon P Genin, J Clin Investigation 2001 107 2 143 151
17. The B sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth. BK Chen MB Feinberg D Baltimore, J Virol 1997 71 7 5495 5504
18. Nutritional aspects of HIV-infected children receiving highly active antiretroviral therapy. TL Miller, AIDS 2003 17 Suppl 1 130 S140
19. Micronutrient intake and malabsorption in HIV infection: a comparison with other malabsorptive states. F Carbonnel L Beaugerie A Abou Rached H D'Almagne W Rozenbaum Y Le Quintrec J Gendre J Cosnes, GUT 1997 41 805 810
20. Vitamins in HIV disease progression and vertical transmission. WW Fawzi DJ Hunter, Epidemiology 1998 9 4 457 466
21. Studies of vitamins and minerals and HIV transmission and disease progression. W Fawzi G Msamanga D Spiegelman DJ Hunter, J Nutrit 2005 135 4 938 944
22. Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy. PK Drain R Kupka F Mugusi WW Fawzi, Am J Clin Nutrit 2007 85 2 333 345
23. A randomized trial of the impact of multiple micronutrient supplementation on mortality among HIV-infected individuals living in Bangkok. S Jiamton J Pepin R Suttent S Filteau B Mahakkanukrauh W Hanshaoworakul P Chaisilwattana P Suthipinittharm P Shetty S Jaffar, AIDS 2003 17 2461 2469
24. Effects of vitamins, including vitamin A, on HIV/AIDS patients. S Mehta W Fawzi, Vitamins and Hormones 2007 75 355 383
25. The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. S Baruchel MA Wainberg, J Leukocyte Biol 1992 52 111 114
26. Antioxidants and progression of human immunodeficiency virus (HIV) disease. M Garland WW Fawzi, Nutrit Res 1999 19 8 1259 1276
27. Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects. JP Allard E Aghdassi J Chau C Tam CM Kovacs IE Salit SL Walmsley, AIDS 1998 12 1653 1659
28. Supplementation with antioxidant vitamins prevents oxidative modification of DNA in lymphocytes of HIV-infected patients. P Jaruga B Jaruga D Gackowski A Olczak W Halota M Pawlowska R Olinski, Free Radical Biology & Medicine 2002 32 5 414 420
29. α-Tocopherol as an antiretroviral therapy supplement for HIV-1-infected patients for increased lymphocyte viability. O de Souza Jr A Treitinger GL Baggio C Michelon JC Verdi J Cunha SIACP Ferreira C Spada, Clin Chem Lab Med 2005 43 4 376 382
30. Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. JH Humphrey PJ Iliff ET Marinda KM Mutasa LH Moulton H Chidawanyika BJ Ward KJ Nathoo LC Malaba LS Zijenah P Zvandasara R Ntozini F Mzengeza AI Mahomva AJ Ruff MT Mbizvo CD Zunguza the ZVITAMBO Study Group, J Infect Dis 2006 193 860 871
31. Effect of prenatal vitamin supplementation on lower-genital levels of HIV type 1 and interleukin type 1 at 36 weeks of gestation. W Fawzi G Msamangaf G Antelman C Xu E Hertzmark D Spiegelman D Hunter Anderson David, Clin Infect Dis 2004 38 716 722
32. Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality. WW Fawzi GI Msamangaf D Hunter B Renjifo G Antelman H Bang K Manji S Kapigad D Mwakagile M Essex D Spiegelman, AIDS 2002 16 1935 1944
33. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers. D Slain JR Amsden RA Khakoo MA Fisher D Lalka GR Hobbs, Pharmacotherapy 2005 25 165 170
34. Injecting drug use (IDU) and prisons. WHO, 2009 http://www.who.int/hiv/ topics/idu/en/index.html
35. Oxidative stress in HIV-1-infected injection drug users. AM Tang E Smit, J Acq Imm Def Synd 2000 25 12 S18
36. MA Nowak RM May, Virus dynamics: mathematical perspectives of immunology and virology Oxford University Press 2000
37. + T cells. AS Perelson DE Kirschner R De Boer, Math Biosci 1993 114 81 125
38. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. P van den Driessche J Watmough, Math Biosci 2002 180 29 48
39. R Smith? Modelling disease ecology with mathematics American Institute of Mathematical Sciences 2008
40. Ascorbate peroxidase, a scavenger of hydrogen peroxide in glyoxysomal membranes. K Karyotou RP Donaldson, Arch Biochem Biophys 2005 434 248 257
41. Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance. M Levine C Conry-Cantilena Y Wang RW Welch PW Washko KR Dhariwal JB Park A Lazarev JF Graumlich J King LR Cantilena, Proc Nat Acad Sci 1996 93 3704 3709
42. Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion. JF Graumlich TM Ludden C Conry-Cantilena LR Cantilena Jr Y Wang M Levine, Pharmaceut Res 1997 14 9 1133 1139
43. A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age. R Manfredi F Chiodo, AIDS 2000 14 10 1475 1477
44. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. D Finzi M Hermankova T Pierson LM Carruth C Buck RE Chaisson TC Quinn K Chadwick J Margolick R Brookmeyer J Gallant M Markowitz DD Ho DD Richman RF Siliciano, Science 1997 278 1295 1300
45. S Hickey H Roberts, Ascorbate: the science of vitamin C Lulu Press 2004
46. Adherence and drug resistance: predictions for therapy outcome. LM Wahl MA Nowak, Proc R Soc Lond 2000 267 835 843
47. Intestinal ischemia and reperfusion injury in transgenic mice overexpressing copper-zinc superoxide dismutase. DR Deshmukh O Mirochnitchenko VS Ghole D Agnese PC Shah M Reddell RE Brolin M Inouye, Am Physiol Soc 1997 273 Cell Physiology 42 1130 C1135
48. Superoxide dismutase and catalase do not affect the pulmonary hypertensive response to group B streptococcus in the lamb. DT Carpenter HR Larkin AS Chang E Morris JT O'Neill J Curtis, Pediatric Research 2001 49 2 181 188
49. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. H Mohri AS Perelson K Tung RM Ribeiro B Ramratnam M Markowitz R Kost A Hurley L Weinberger D Cesar MK Hellerstein DD Ho, J Exp Med 2001 194 9 1277 1287
50. + T cells depleted? RM Ribeiro H Mohri DD Ho AS Perelson, Proc Nat Acad Sci USA 2002 99 24 15572 15577
51. Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapy. M Di Mascio RM Ribeiro M Markowitz DD Ho AS Perelson, Math Biosci 2004 188 1-2 47 62
52. Hydrogen peroxide as a second messenger in lymphocyte activation. M Reth, Nat Immunol. 2002 3 12 1129 1134
53. Measurements of oxidative stress status and antioxidant activity in chronic leukaemia patients. MM Al-Gayyar LA Eissa AM Rabie AM El-Gayar, J Pharmac Pharmacol 2007 59 409 417